Adaptin Bio, Inc. Liquidation Value
APTN
Other
Cash & Equivalents
$459,174
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $459,174
Total Obligations: -$2.11M
$-1.65M
Per share: $-0.19
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $459,174
AR: $0
Total Obligations: -$2.11M
$-1.65M
Per share: $-0.19
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $459,174
AR: $0
Inventory: $0
Total Obligations: -$2.11M
$-1.65M
Per share: $-0.19
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-1.65M | $-0.19 |
| Liquid Liquidation Value | $-1.65M | $-0.19 |
| Operating Liquidation Value | $-1.65M | $-0.19 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $459,174 |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $2.11M |
| Long-term Debt | N/A |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 8.7M |
Explore all 87 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $459,174 | N/A | N/A | $1.51M | $2.11M | N/A | N/A | N/A |
| 2025-09-30 | $579,089 | N/A | N/A | $1.34M | $1.86M | N/A | N/A | N/A |
| 2025-06-30 | $1.35M | N/A | N/A | $666,570 | $1.19M | N/A | N/A | N/A |
| 2025-03-31 | $2.37M | N/A | N/A | $327,057 | $1.11M | N/A | N/A | N/A |
| 2024-12-31 | $34,085 | N/A | N/A | $1.36M | $4.34M | N/A | N/A | N/A |
| 2024-09-30 | $115,308 | N/A | N/A | N/A | $235,640 | N/A | N/A | N/A |
| 2024-06-30 | $23,776 | N/A | N/A | N/A | $205,989 | N/A | N/A | N/A |
| 2024-03-31 | $380 | N/A | N/A | N/A | $170,451 | N/A | N/A | N/A |
▼ Community Notes